Downstream ability to cross-sell obesity subscribers into other verticals
(Again, all participants were advised to cut 500 calories a day and do 150 minutes of exercise each week.) The drug is priceyabout $1,350 per monthand neither Medicare nor many insurance plans cover the cost...though they typically cover Ozempic if patients have type 2 diabetes
Optimise nutritional intake despite reduced appetite
GLP-1 microdosing is an innovative approach designed for men and women who only need to lose a few extra pounds
Food and Drug Administration (FDA) has now approved two oral GLP-1 drugs: an oral version of Novo Nordisks Wegovy at the end of 2025, and Eli Lillys daily, non-peptide pillorforglipron, a distinct competitor to oral semaglutide and different from Eli Lillys injectable tirzepatidecalled Foundayo in April, which is notable because it can be taken without restrictions on timing or food or water intake
A small protein-rich snack is better than nothing